In a meta-analysis of RCTs investigating CIN development [20], ACE inhibitors were not significant risk factors (OR 1.06, 95% CI 0.69–1.61, p = 0.8). The gene discussed is ACE; the disease is cervical squamous intraepithelial neoplasia.